We're thrilled to announce the Anaqua and PatSnap partnership. Together, we'll combine our cutting-edge technologies and capabilities to enable best practices in the management of Intellectual Property for our Life Science clients.

Anaqua AQX® Pharma helps clients manage the business processes of Pharmaceutical IP Management, while Synapse enables drug discovery through external and competitor AI-powered drug discovery processes. Our integrated solution powers end-to-end Product IP Management including stage gate-driven reviews of changes in the external considerations and environment.

Through this partnership, AQX customers get unlimited access to PatSnap's life sciences innovation intelligence solution, Synapse. Combined, these platforms allow users to uncover associations between diseases, target companies, and drugs while improving R&D and accelerating time to market.